Interested in becoming a COVID-19 Vaccine Provider?

Please follow the steps below to enroll.

C19_VPPE.pngReview Collect ICARE Storage Toolkit

A printable guide to enrollment can be downloaded here a web version is available here.

 

Please note: Completion of COVID-19 vaccine enrollment does not guarantee a facility will receive COVID-19 vaccine. Doses will be allocated based on vaccine availability, vaccine storage capacity, and facilities serving priority groups as defined by the National Academies of Sciences, Engineering and Medicine and the Advisory Committee on Immunization Practice (ACIP).

Important note for Hospitals:  Hospitals that previously enrolled sites in REDCap do not need to complete the COVID-19 provider enrollment in I-CARE. CDPH completed the COVID-19 enrollment in I-CARE for these sites.

Vaccinating Persons with History of Allergies

CDC has issued an MMWR on anaphylaxis reactions for the Pfizer-BioNtech vaccine. 21 cases of anaphylaxis are reported of a total of 1,893,360 vaccine doses administered. 17 of these 21 had a history of allergies or allergic reaction and 7 of these had a history of anaphylaxis. 71% of reported anaphylaxis episodes occurred within the first 15 minutes of vaccination. Read the full report here.

 

Find full considerations from CDC here including detailed updated information on clinical considerations. Guidelines were updated by CDC on 3/5/21 - including clarifications on contraindications and precautions.

 

Resources and Information for Vaccine Providers

NEW: For updates regarding billing in IL and for IL medicaid patients.

Information on Operation Warp Speed (HHS site)

Post Vaccine Considerations for Healthcare Personnel - Side effect or COVID-19 symptoms?

Preparing for the Potential Management of Anaphylaxis at COVID-19 Vaccination Sites

Pre-vaccination checklist for COVID 19 Vaccines

COVID-19 Vaccine Temperature Log - Fahrenheit

COVID-19 Vaccine Temperature Log - Celsius

 

ACIP has issued vaccine priority guidance for phase 1b, 1c, and 2. Find full recommendations here.

 

 

Chicago has published vaccine priority phases based on Illinois and ACIP guidance. Find updated details on Vaccine priority in Chicago on our website.

URGENT: CDC and FDA Pause Use of Johnson & Johnson COVID-19 Vaccine - April 16, 2021

Safety is our top priority. In accordance with the CDC and FDA, the City of Chicago paused the use of the Johnson & Johnson (J&J) vaccine while the CDC and FDA reviews all of the information. The ACIP held an emergency meeting on April 14 and recommended to continue the pause of J&J while more data is collected, and they will reconvene when sufficient data becomes available, currently scheduled for Friday, April 23. Vaccination remains critical to protecting Chicagoans and we’ll share more information as it becomes available.

Pages available for specific COVID-19 Vaccines

For Pfizer-BioNTech COVID-19 Vaccine Information please click here.

For Moderna COVID-19 Vaccine Information please click here.

For Johnson & Johnson Janssen COVID-19 Vaccine Information please click here.

Announcements

As of April 19, all Chicagoans age 16 and up are eligible for vaccination in Chicago (phase 2).

 

The Johnson & Johnson COVID-19 vaccine was officially granted Emergency Use Authorization (EUA) by the FDA on February 27, 2021 and recommended by the CDC Advisory Committee on Immunization Practices (ACIP) on February 28, 2021. Find J&J specific materials linked above.

NEW Product Information Guide (v7 issued March 2, 2021)

NEW Ancillary kit syringe and needle deficiency reporting

NEW COVID-19 Vaccine Provider Videos 

Race/Ethnicity Reporting Updates (2/16/21)

Quick Provider Ordering Tips (2/16/21)

VaccineFinder Inventory Reporting in 3 Easy Steps (2/16/21)

Instructions on signing up for ZocDoc (2/8/2021)

CDPH has compiled a provider toolkit which can be used to engage patients and employees eligible for vaccine. Find here under the "toolkits" tab.

NEW  CDPH Provider Update - issued Jan 28, 2021

CDC has issued an MMWR on anaphylaxis reactions for the Pfizer-BioNtech vaccine. 21 cases of anaphylaxis are reported of a total of 1,893,360 vaccine doses administered. 17 of these 21 had a history of allergies or allergic reaction and 7 of these had a history of anaphylaxis. 71% of reported anaphylaxis episodes occurred within the first 15 minutes of vaccination. Read the full report here.

 

Covid-19 Vaccination Chicago Provider Letter from CDPH - posted 12/18/2020

See the CDC site for updated reporting on total administered vaccine doses in the USA.

COVID-19 Vaccine Contact Information

 

Please direct all questions to COVID19vaccine@cityofchicago.org.

 

Please visit the Illinois Department of Public Health I-CARE website for information on enrolling a facility or individual in I-CARE: https://www.dph.illinois.gov/topics-services/prevention-wellness/immunization/icare

 

For information on the vaccine please go to: www.chicago.gov/covidvax.

COVID 19 Vaccine Providers Updates

Videos for COVID-19 Vaccine Providers - issued Jan 28, 2021

Phase 1B Week 3 for COVID-19 Vaccine Providers - issued Feb 9, 2021

COVID-19 Situational Awareness Webinars

Please stay up to date with healthcare webinars!

Register for the webinars here

Previous Situational Awareness Presentations

October 30, 2020

November 6, 2020

November 20, 2020

December 4, 2020

December 11, 2020

December 18, 2020

January 8, 2021 and supplemental handout

January 22, 2021

February 5, 2021

February 19, 2021

March 5, 2021

March 19, 2021

April 2, 2021

Vaccination Options for Healthcare Personnel Not Affiliated with Hospitals or Health Systems

 

Healthcare workers continue to be eligible for vaccination as we move through phase 1b and into phase 1c.

 

If you are a healthcare worker who is having difficulty accessing vaccination please email us at covid19vaccine@cityofchicago.org.